DannyLascanoMD
General Surgery • Santa Monica, CAColon & Rectal Surgery, Hepatobiliary Surgery, Melanoma, Pancreas
CGSO Fellow at St. John Cancer Institue
Dr. Lascano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2121 Santa Monica Blvd
Santa Monica, CA 90404Phone+1 310-315-6125Fax+1 310-582-7163
Summary
- Dr. Danny Lascano is a general surgeon in Santa Monica, CA and is affiliated with Providence Saint John's Health Center. He graduated from Columbia University College of Physicians and Surgeons. He completed general surgery residency at WCMC- New York Medical College. He specializes in melanoma , general surgery, and surgical oncology. He has more than 20 publications and over 350 citations.
Education & Training
Westchester Medical CenterResidency, Surgery, 2016 - 2023
Columbia University Vagelos College of Physicians and SurgeonsClass of 2016
Certifications & Licensure
CA State Medical License 2019 - 2025- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Ferdinand C. Valentine Resident Essay Contest Winner New York Academy of Medicine, 2015
- Ferdinand C. Valentine Medical Student Research Grant New York Academy of Medicine, 2015
- NIH T35 Grant NIDDK-NIH, 2014
Clinical Trials
- Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer Start of enrollment: 2014 Apr 09
Publications & Presentations
PubMed
- 19 citationsMixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcomeTina Schubert, Matthew R. Danzig, Srinath Kotamarti, Rashed Ghandour, Danny Lascano
World Journal of Urology. 2015-06-01 - 91 citationsFrailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.Meera Chappidi, Max Kates, Hiten D. Patel, Jeffrey J. Tosoian, Deborah R. Kaye
Urologic Oncology. 2016-06-01 - 10 citationsInitiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice.Michael J. Zobel, Abigail K. Zamora, Hong-Wei Wu, Jianping Sun, Danny Lascano
Journal for Immunotherapy of Cancer. 2020-12-01
Other Languages
- Spanish
Reviews
Very good bedside manner. I found him to be very reassuring in his role. Nice meeting you Thank you
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
